A big rally on Wall Street Monday fueled by the weakness in the U.S. dollar. Stocks are back in the black for the year after the Dow Jones Industrial average gained 228 points. Crude slipped again to settle at $43.88 a barrel. DuPont (DD) was blue chip's biggest decliner. Shares fell more than 4% after being hit with a double blow. The stock was downgraded at BofA Merrill Lynch to an UNDERPERFORM from BUY rating. This comes amid an ongoing proxy fight with activist investor, Trian Fund Management. Sealing the deal had a couple of drugmakers higher. Valeant Pharmaceuticals (VRX) agreed to buy Salix Pharmaceuticals (SLXP) for $173 a share. Elon Musk's tweet saying Tesla's (TSLA) Model S was about to 'end range anxiety' drove its stock more than 3% higher.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
More from Video
How the Cannabis Industry Is Getting a High-Tech Facelift
There is a lot of buzz about the pot industry from legislation to consolidation to investing. Watch the video to learn how technology could be the key to cannabis success.
Another Day, Another Deal: What to Watch from AbbVie, Allergan, Micron, Buffett
Wall Street woke up to another major deal. Here's what to watch from AbbVie's acquistion of Allergan, Warren Buffett's Kraft comments and Micron earnings after the bell.